PRICE 2: A phase 3 randomized controlled trial of phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections
PRICE 2: A phase 3 randomized controlled trial of phlebotomy resulting in controlled hypovolemia to prevent blood loss in major hepatic resections
批准号:
372703
负责人:
Martel Guillaume
金额:
$36.22万
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-09-01 至 2021-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The need for major liver surgery is growing rapidly. Despite improvements in techniques, these operations continue to carry a significant risk of hemorrhage and blood transfusion. Hypovolemic phlebotomy represents a simple, cheap, safe, and underreported
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
-
批准号:463049
-
项目类别:Operating Grants
-
资助金额:$5.29万
-
财政年份:2022
-
负责人:Martel Guillaume
-
依托单位:
A Delphi survey to generate consensus among international experts on elements of an intraoperative transfusion protocol
-
批准号:460778
-
项目类别:Miscellaneous Programs
-
资助金额:$1.09万
-
财政年份:2022
-
负责人:Martel Guillaume
-
依托单位:
DRAGON 2 - An international multicenter randomized controlled trial to compare combined Portal and Hepatic Vein Embolization (PVE/HVE) with PVE alone in liver surgery
-
批准号:463216
-
项目类别:Operating Grants
-
资助金额:$46.83万
-
财政年份:2022
-
负责人:Martel Guillaume
-
依托单位:
海外基金